UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant To Section 13 or 15(d)
of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 9 8, 2006

AKSYS, LTD.

(Exact name of registrant as specified in its charter)

000-28290

000-28290
(Commission File Number)

Delaware	36-3890205
(State or other jurisdiction ofincorporation or organization)	(I.R.S. Employer Identification No.)

Two Marriott Drive Lincolnshire, Illinois 60069
(Address of principal executive offices, with zip code)

(847) 229-2020
(Registrant’s telephone number, including area code)

Not Applicable
(Former name or former address, if changed since last report)

~~(Commission~~Check ~~File~~the ~~Number~~appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):

Delaware	36-3890205
(State or other jurisdiction of	(I.R.S. Employer Identification No.)
incorporation or organization)

o Written communications pursuant to Rule 425 under the Securities Act

~~Two~~o Soliciting ~~Marriott Drive~~material ~~Lincolnshire,~~pursuant ~~Illinois 60069~~to Rule 14a-12 under the Exchange Act

~~(Address~~o Pre-commencement communications ofpursuant ~~principal~~to ~~executive~~Rule ~~offices,~~14d-2(b) ~~with~~under ~~zip code)~~the Exchange Act

o Pre-commencement communications pursuant to Rule 13e-4(~~847~~c) ~~229-2020~~under the Exchange Act

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 8.01. Other Events.

On June 9 19, 2006, Aksys, Ltd. ~~(the “Company”)~~ issued a press release announcing ~~regarding~~that ~~the~~it ~~planned change~~received in a ~~majority~~warning ofletter ~~its~~dated ~~directors~~June ~~and~~8, 2006 (the ~~anticipated~~“Warning Letter”) ~~closing~~from ~~date~~the Office of ~~the securities~~Compliance, ~~purchase~~Center ~~agreement~~for ~~previously~~Devices ~~entered~~and ~~into~~Radiological Health byof the ~~Company~~U.S. Food and ~~Durus Life~~Drug ~~Sciences~~Administration ~~Master~~(the ~~Fund, Ltd~~“FDA”). A copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference. A copy of the Warning Letter is attached hereto as Exhibit 99.2 and incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.		Document

99.1		Press Release dated June 19, 2006

99.2		Warning Letter from the US Food and Drug Administration to Aksys, Ltd. dated June 8, 2006

Exhibit No.		Description
99.1		Press release issued June 9, 2006, by the Company regarding planned change in majority of directors

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

		AKSYS, LTD.
Date: June 20, 2006
Dated: June 15, 2006		By:	/s/ Laurence P. Birch
	AKSYS, LTD.
			Name: Laurence P. Birch
	By:	/s/ Laurence P. Birch
			Title: Chief Financial Officer and Interim
		Laurence P. Birch
			President and Chief Executive Officer
	Its:	Chief Financial Officer and Interim President and Chief Executive Officer

Filing Compare · AKSYS LTD